# Contemporary 0.55 T MRI to visualize interstitial lung disease – An exploratory study

**Authors:** Nadine Bayerl, Claudius S. Mathy, Christina Bergmann, Tobias Bäuerle, Lisa C. Adams, Armin M. Nagel, Jörg H.W. Distler, Teresa Gerhalter, Michael Uder, Rafael Heiss, Stephan Ellmann

PMC · DOI: 10.1016/j.ejro.2025.100720 · 2026-01-05

## TL;DR

This study explores whether 0.55T MRI can be used to visualize lung disease as effectively as CT scans, finding it promising but needing improvement.

## Contribution

The study is the first to explore contemporary 0.55T MRI as a radiation-free alternative for assessing interstitial lung disease.

## Key findings

- 0.55T MRI showed comparable overall disease extent to HRCT with no significant difference.
- MRI overestimated ground-glass opacities and underestimated reticulation compared to HRCT.
- Despite limitations, 0.55T MRI is a promising radiation-free imaging option for ILD.

## Abstract

To evaluate the feasibility of contemporary 0.55 T MRI for visualizing interstitial lung disease (ILD) compared to high-resolution computed tomography (HRCT) in an exploratory first-experience study.

Thirty participants (mean age 60 ± 13 years; 13 females) with rheumatologic ILD underwent HRCT and 0.55 T MRI within 31 days. MRI protocols included proton-density-weighted turbo-spin-echo sequences (transverse) and T2-weighted short-tau inversion recovery sequences (coronal). Three blinded radiologists independently assessed overall disease extent, ground-glass opacity (GGO), reticulation, and emphysema using a semi-quantitative scoring system. Differences between modalities were tested using Wilcoxon signed-rank tests, and Bland-Altman analysis evaluated systematic bias.

Overall disease extent showed no statistically significant difference between low-field MRI and HRCT (median 22.5 % vs. 24.5 %), with excellent interobserver agreement (MRI ICC = 0.94; HRCT ICC = 0.97). MRI significantly overestimated GGO (13.1 % vs. 9.7 %) and underestimated reticulation (8.1 % vs. 11.4 %) compared to HRCT. Bland-Altman analysis confirmed no systematic bias for overall disease extent but consistent overestimation of GGO and underestimation of reticulation on MRI.

Contemporary 0.55 T MRI showed no statistically significant difference in overall ILD extent compared to HRCT but tended to overestimate GGO and underestimate reticulation. Despite these limitations, 0.55 T MRI represents a promising candidate for future development as a radiation-free alternative for gross disease burden assessment in ILD, warranting further technical refinement before routine clinical use.

•Contemporary 0.55 T MRI assessed ILD extent comparably to HRCT.•Ground-glass opacities were overestimated and reticulations underestimated on 0.55 T MRI compared to HRCT.•0.55 T MRI shows promise as a radiation-free ILD imaging option in the future.•Technical advancements are needed before considering clinical use.

Contemporary 0.55 T MRI assessed ILD extent comparably to HRCT.

Ground-glass opacities were overestimated and reticulations underestimated on 0.55 T MRI compared to HRCT.

0.55 T MRI shows promise as a radiation-free ILD imaging option in the future.

Technical advancements are needed before considering clinical use.

## Linked entities

- **Diseases:** interstitial lung disease (MONDO:0015925)

## Full-text entities

- **Diseases:** ILD (MESH:D017563), emphysema (MESH:D004646)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12810502/full.md

---
Source: https://tomesphere.com/paper/PMC12810502